Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019;20(1):8-14.
doi: 10.1080/15384047.2018.1504719. Epub 2018 Sep 25.

A 4-month-old boy with gastrointestinal stromal tumor of mesocolon

Xuquan Jing M.D  1 , Xue Meng M.D, Ph.D  1 , Yongsheng Gao M.D, Ph.D  2 , Jinming Yu M.D, Ph.D  1 , Bo Liu M.D, Ph.D  3
Affiliations
Case Reports

A 4-month-old boy with gastrointestinal stromal tumor of mesocolon

Xuquan Jing M.D et al. Cancer Biol Ther. 2019.

Abstract

Gastrointestinal stromal tumors (GISTs) are very uncommon in pediatric patients, and they are distinct clinical-pathological and molecular deviations from their adult counterparts. Most pediatric GISTs lack the c-kit or platelet-derived growth factor receptor alpha (PDGFRA) genes mutations. To date, there is no published standard guidelines available for the best treatment of pediatric GISTs, especially for infant GIST. Therefore, we report a case of 4-month-old infant with GIST of mesocolon without KIT/PDGFRA mutation. We also review the clinical, biological, and genetic features of pediatric GISTs and re-think several questions that could affect clinical practice.

Keywords: CCND2; GIST; PTCH1; adult; imatinib; pediatric; young.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Abdominal contrast-enhanced computed tomography scan showed a tumor (diameter, 4.6cm× 6.3cm) located in mesocolon.
Figure 2.
Figure 2.
Hematoxylin–eosin staining showed spindle cell morphology.
Figure 3-5
Figure 3-5
Immunehistochemical analyses were positive for CD117 (Fig.3), PDGFR (Fig.4), Vimentin (Fig.5).
Figure 6.
Figure 6.
Immunehistochemical analyses showed negative for the expression of succinate dehydrogenase B (SDHB).
Figure 7-8.
Figure 7-8.
Mutational analysis showed a wild type for KIT (exons 9, 11, 13, 17, 18) (Fig.7) and HER2 (HER2/CEP17 1.0) (Fig.8).
Figure 9.
Figure 9.
Re-image found metastases of omentum, mesentery, retroperitoneum, inguinal lymph node and abdominal wall two months after surgery.
See this image and copyright information in PMC

References

    1. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002;33(5):459–465. - PubMed
    1. Miettinen M, Lasota J.. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466–1478. - PubMed
    1. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet (London, England). 2013;382(9896):973–983. doi:10.1016/S0140-6736(13)60106-3. - DOI - PubMed
    1. Benesch M, Wardelmann E, Ferrari A, Brennan B, Verschuur A. Gastrointestinal stromal tumors (GIST) in children and adolescents: A comprehensive review of the current literature. Pediatric Blood & Cancer. 2009;53(7):1171–1179. doi:10.1002/pbc.22123. - DOI - PubMed
    1. Martin-Broto J, Rubio L, Alemany R, Lopez-Guerrero JA. Clinical implications of KIT and PDGFRA genotyping in GIST. Clin Transl Oncol. 2010;12(10):670–676. doi:10.1007/s12094-010-0576-7. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources